Investigation of topical solution of cow's milk exosome in the treatment of androgenic hair loss

Investigating the safety and effectiveness of topical solution containing exosomes derived from cow's milk in the treatment of androgenic hair loss compared to 5% minoxidil topical solution

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N69

Enrollment

Registered

2025-12-29

Start date

2026-01-05

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia. Androgenic alopecia, unspecified

Interventions

Intervention 1: Intervention group: Patients will apply 3 cc of milk exosomes topically to the recommended areas twice a day (morning and night) for 3 months. Intervention 2: Control group: Patients w

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Not using topical or oral medication for the treatment of alopecia during the last six months AGA type 2-4

Exclusion criteria

Exclusion criteria: Age under18 years pregnancy breastfeeding History of malignant diseases Taking any topical or systemic treatment during the study

Design outcomes

Primary

Measure	Time frame
Hair density. Timepoint: before starting the treatment and one month after the end of the treatment period (end of the fourth month). Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient.	—

Measure

Time frame

Hair density. Timepoint: before starting the treatment and one month after the end of the treatment period (end of the fourth month). Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient.

—

Secondary

Measure	Time frame
Side effects. Timepoint: During use. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: One month after the last meeting. Method of measurement: Satisfaction survey (scoring from 1 to 10) and observation.;Tolerability. Timepoint: During use. Method of measurement: Questionnaire and visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026